The pharmaceutical industry imports in the Netherlands have demonstrated notable fluctuations over the past decade. From 2013, values increased marginally to 2014, followed by a steep decline in 2015. The period between 2016 and 2019 showed a recovery with fluctuating growth rates, peaking significantly in 2020 and 2021. By 2023, the imports stood at 25.99 billion US dollars, marking a minimal year-on-year increase. The CAGR over the last five years is 9.11%, suggesting sustained growth despite the minor fluctuations in the most recent years. Forecasts predict a steadier yet modest growth trajectory toward 2028.
Future trends to watch for include:
- Emerging markets and their impact on import dependencies.
- Technological advancements in pharmaceuticals altering import-export dynamics.
- Regulatory changes in Europe affecting trade flows.
- Potential disruptions due to geopolitical factors and global health crises.
